Publications
Detailed Information
Development of technologies aiding large-tissue engineering
Cited 94 time in
Web of Science
Cited 105 time in Scopus
- Authors
- Issue Date
- 1998-01
- Publisher
- AMER CHEMICAL SOC
- Citation
- BIOTECHNOLOGY PROGRESS, Vol.14 No.1, pp.134-140
- Abstract
- There are many clinical situations in which a large tissue mass is required to replace tissue lost to surgical resection (e.g. mastectomy). It is possible that autologous cell transplantation on biodegradable polymer matrices may provide a new therapy to engineer large tissue which can be used to treat these patients. A number of challenges must be met to engineer a large soft tissue mass. These include the design of (1) a structural framework to maintain a space for tissue development, (2) a space-filling matrix which provides for localization of transplanted cells, and (3) a stragegyto enhance vascularization of the forming tissue. in this paper we provide an overview of several technologies which are under development to address these issues. Specifically, support matrices to maintain a space for tissue development have been fabricated from polymers of lactide and glycolide. The ability of these structures to resist compressive forces was regulated by a ratio lactide to glycolide in the polymer. Smooth muscle cell seeding onto polyglycolide fiber-based matrices has been optimized to allow formation of new tissues in vitro and in vivo. Finally, polymer microsphere drug delivery technology is being developed to release vascular endothelial growth factor (VEGF), a potent angiogenic molecule, at the site of tissue formation. This strategy, which combines several different technologies, may ultimately allow for engineering of large soft tissues.
- ISSN
- 8756-7938
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.